Hayat Pharmaceutical Industries Balance Sheet Health
Financial Health criteria checks 5/6
Hayat Pharmaceutical Industries has a total shareholder equity of JOD28.6M and total debt of JOD3.4M, which brings its debt-to-equity ratio to 12%. Its total assets and total liabilities are JOD35.7M and JOD7.1M respectively. Hayat Pharmaceutical Industries's EBIT is JOD3.6M making its interest coverage ratio 28.7. It has cash and short-term investments of JOD6.9M.
Key information
12.0%
Debt to equity ratio
د.أ3.42m
Debt
| Interest coverage ratio | 28.7x |
| Cash | د.أ6.87m |
| Equity | د.أ28.63m |
| Total liabilities | د.أ7.06m |
| Total assets | د.أ35.69m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: HPIC's short term assets (JOD22.6M) exceed its short term liabilities (JOD5.1M).
Long Term Liabilities: HPIC's short term assets (JOD22.6M) exceed its long term liabilities (JOD2.0M).
Debt to Equity History and Analysis
Debt Level: HPIC has more cash than its total debt.
Reducing Debt: HPIC's debt to equity ratio has increased from 10.8% to 12% over the past 5 years.
Debt Coverage: HPIC's debt is well covered by operating cash flow (34.6%).
Interest Coverage: HPIC's interest payments on its debt are well covered by EBIT (28.7x coverage).